Human chorionic gonadotropin follow-up in patients with molar pregnancy: A time for reevaluation

Obstetrics and Gynecology

Volumn 101, Issue 4, 2003, Pages 732-736

  Feltmate, Colleen M ^b   Batorfi, Jozsef ^b   Fulop, Vilmos ^b   Goldstein, Donald P ^a   Doszpod, Jozsef ^b   Berkowitz, Ross S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Brigham and Women's Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN;

ADOLESCENT; ADULT; AGE; ARTICLE; CANCER RECURRENCE; FEMALE; FOLLOW UP; HEALTH INSURANCE; HORMONE BLOOD LEVEL; HUMAN; HYDATIDIFORM MOLE; MAJOR CLINICAL STUDY; MARRIAGE; PARITY; PREGNANCY; PRIORITY JOURNAL; RANDOMIZATION;

EID: 0037380115     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(03)00009-7     Document Type: Article

References (17)

1. Kohorn E.I. Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut. Obstet Gynecol. 59:1982;78-84.
2. Lurain J.R., Brewer J.I., Torok E.E., Halpern B. Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol. 145:1983;591-595.
3. Soper J.T., Clarke-Pearson D., Hammond C.B. Metastatic gestational trophoblastic disease: Prognostic factors in previously untreated patients. Obstet Gynecol. 71:1988;338-343.
4. Bolis G., Belloni C., Bonazzi C., Mangili G., Presti M., Zanaboni F., et al. Analysis of 309 cases after hydatidiform mole: Different follow-up program according to biologic behavior. Tumori. 74:1988;93-96.
5. Berkowitz R.S., Goldstein D.P. Chorionic tumors. N Engl J Med. 335:1996;1740-1748.
6. Seckl M.J., Fisher R.A., Salerno G., Rees H., Paradinas F.J., Foskett M., et al. Choriocarcinoma and partial hydatidiform moles. Lancet. 356:2000;36-39.
7. Bagshawe K.D., Lawler S.D., Paradinas F.J., Dent J., Brown P., Boxer G.M. Gestational trophoblastic tumors following initial diagnosis of partial hydatidiform mole. Lancet. 335:1990;1074-1076.
8. Garner E.I.O., Lipson E., Bernstein M.R., Goldstein D.P., Berkowitz R.S. Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor. J Reprod Med. 47:2002;380-386.
9. Kim J.H., Park D.C., Bae S.N., Namkoong S.E., Kim S.J. Subsequent reproductive experience after treatment for gestational trophoblastic disease. Gynecol Oncol. 71:1998;108-112.
10. Woolas R.P., Bower M., Newlands E.S., Seckl M., Short D., Holden L. Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome. Br J Obstet Gynaecol. 105:1998;1032-1035.
11. Ngan H.Y., Wong L.C., Ma H.K. Reproductive performance of patients with gestational trophoblastic disease in Hong Kong. Acta Obstet Gynecol Scand. 67:1988;11-14.
12. American College of Obstetricians and Gynecologists. Management of gestational trophoblastic disease. ACOG technical bulletin no. 178. Washington: American College of Obstetricians and Gynecologists, 1993.
13. Schlaerth J.B., Morrow C.P., Kletzky O.A., Nalick R.H., D'Ablaing G.A. Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy. Obstet Gynecol. 58:1981;478-482.
14. Kim D.S., Moon H., Kim K.T., Moon Y.J., Hwang Y.Y. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole. Obstet Gynecol. 67:1986;690-694.
15. Massad L.S., Abu-Rustum N.R., Lee S.S., Renta V. Poor compliance with postmolar surveillance and treatment protocols by indigent women. Obstet Gynecol. 96:2000;940-944.
16. Paradinas F.J., Browne P., Fisher R.A., Foskett M., Bagshawe K.D., Newlands E. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions. Histopathology. 28:1996;101-110.
17. Rob L., Rovova H., Pluta M., Kulovany E., Hrehorcak M., Chmel R., et al. Regression of hCG in various types of molar pregnancies - clinical course and prognosis. Ceska Gynecol. 66:2001;230-235.